VENTO, Sandro
 Distribuzione geografica
Continente #
NA - Nord America 3.151
EU - Europa 2.600
AS - Asia 1.872
SA - Sud America 477
AF - Africa 31
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.141
Nazione #
US - Stati Uniti d'America 3.109
SG - Singapore 842
GB - Regno Unito 823
CN - Cina 576
RU - Federazione Russa 558
BR - Brasile 418
DE - Germania 199
SE - Svezia 199
FR - Francia 194
IE - Irlanda 192
FI - Finlandia 187
HK - Hong Kong 178
IT - Italia 105
VN - Vietnam 91
KR - Corea 69
UA - Ucraina 66
AR - Argentina 24
CA - Canada 20
IN - India 19
TR - Turchia 19
ZA - Sudafrica 17
BE - Belgio 14
JP - Giappone 13
MX - Messico 13
NL - Olanda 13
BD - Bangladesh 12
CZ - Repubblica Ceca 12
EC - Ecuador 12
ID - Indonesia 12
IL - Israele 10
ES - Italia 9
PL - Polonia 7
AU - Australia 6
CO - Colombia 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
IQ - Iraq 5
AT - Austria 4
EG - Egitto 4
MA - Marocco 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
LT - Lituania 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EU - Europa 2
GR - Grecia 2
LV - Lettonia 2
NO - Norvegia 2
PK - Pakistan 2
RO - Romania 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
CD - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
GE - Georgia 1
GN - Guinea 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MN - Mongolia 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
RE - Reunion 1
SI - Slovenia 1
SV - El Salvador 1
VE - Venezuela 1
Totale 8.141
Città #
Southend 726
Jacksonville 602
Woodbridge 459
Singapore 401
Chandler 380
Ann Arbor 198
Dublin 192
Dallas 184
Hong Kong 177
Ashburn 149
Houston 101
Moscow 95
Beijing 82
Lawrence 77
Princeton 77
Wilmington 72
Nanjing 63
Los Angeles 51
Jinan 46
Shenyang 45
New York 44
Ho Chi Minh City 30
São Paulo 30
Helsinki 29
Hebei 28
Buffalo 26
Santa Clara 26
Munich 25
Nanchang 24
Changsha 23
Sindelfingen 23
Milan 22
Turku 22
Redondo Beach 21
The Dalles 21
Tianjin 21
Jiaxing 19
Hanoi 17
Ningbo 17
San Francisco 16
Haikou 15
Seattle 15
Brussels 14
Denver 13
Norwalk 13
Toronto 13
Verona 13
Zhengzhou 13
Bologna 12
Frankfurt am Main 12
Hangzhou 12
Taizhou 12
Boardman 11
Lanzhou 11
London 11
Rio de Janeiro 11
Belo Horizonte 10
Brno 10
Taiyuan 10
Tokyo 10
Atlanta 9
Curitiba 9
Fairfield 9
Porto Alegre 9
Brooklyn 8
Chennai 8
Haiphong 8
Chicago 7
Guangzhou 7
Johannesburg 7
Phoenix 7
Poplar 7
Redmond 7
Warsaw 7
Fuzhou 6
Limeira 6
Redwood City 6
Salvador 6
Seoul 6
Clearwater 5
Columbus 5
Düsseldorf 5
Montreal 5
Orem 5
Philadelphia 5
Pignone 5
Quito 5
Ribeirão Preto 5
Santo André 5
Stockholm 5
Thái Nguyên 5
Amsterdam 4
Biên Hòa 4
Boston 4
Caxias do Sul 4
Durban 4
Falls Church 4
Ipatinga 4
Jakarta 4
Lages 4
Totale 5.137
Nome #
Aetiology of pneumonia following isolated closed head injury 154
Twice-weekly dapsone for primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1 infection: efficacy, safety and pharmacokinetic data 154
Comparative evaluation of naturally occurring Pneumocystis carinii pneumonia (PCP) and PCP despite primary chemoprophylaxis in patients with AIDS 148
Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load 145
Autoimmune hepatitis type 2 induced by HCV and persisting after viral clearance 140
Raltegravir/nevirapine dual therapy at reduced doses as 'maintenance' treatment in virally suppressed HIV-infected patients 138
Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life 134
Recreational substance use and tolerance of efavirenz in HIV-1 infected patients 132
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient 132
A case of visceral leishmaniasis with protracted incubation in a nonendemic area. 128
Is there a role for TNF-alpha in HIV1-associated lipodystrophy? 125
Does tenofovir increase efavirenz hepatotoxicity? 124
Clinical picture: Ring calcification in the chest X-ray of a 17-year-old girl: coronary aneurism following Kawasaki disease 123
Unusual rapidly growing ulcerative genital mass due to herpes simplex virus in uman immunodeficiency virus-infected woman 121
Cryptococcal meningitis during cyclosporin treatment in a patient with psoriasis. 121
Can we really identify HIV-1 long-term nonprogressors? 121
Mortality due to hepatitis C virus-related cirrhosis in patients infected with HIV type 1: a role for alcohol 119
Enanthema as the first clinical manifestation of abacavir hypersensitivity reaction: a case report. 119
Short-Cycle Therapy (5 days on/2 days off) with a lamivudine-dolutegravir two-drug regimen in a cohort of virologically suppressed HIV-infected patients 119
Adherence to HAART in HIV. 118
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients 118
Recovery of long-term natural protection against reactivation of CMV retinitis in AIDS patients responding to highly active antiretroviral therapy. 118
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients 117
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir 117
Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: clinical implications in patients on CD4 T-cell-guided treatment interruption. 116
Microsporidium species in pulmonary cavitary lesions of AIDS patients infected with Rhodococcus equi 115
Tuberculosis among refugees and displaced people at the Burundi-Rwanda border 114
Steroid and interferon therapy in liver/kidney microsomal antibody-positive patients with chronic hepatitis C 113
Early detection of lung cancer in high-risk patients with HIV-1 infection. 113
Autoimmune hepatitis type 1 after measles 112
Hyperacute unilateral gonococcal endophthalmitis in an HIV-infected man without genital infection 112
Hepatitis A virus infection and atherosclerosis 111
Early detection of lung cancer in high-risk patients with HIV-1 infection. 109
Nosocomial Candidemia in non-neutropenic patients at an Italian tertiary care hospital 106
The PraSight-F rapid dipstick antigen capture assay for monitoring parasite clearance after drug treatment of Plasmodium falciparum malaria 106
Cutaneous abscess due to Eubacterium lentum in injection drug user: a case report and review of the literature 105
Unusual, rapidly growing ulcerative genital mass due to herpes simplex virus in a human immunodeficiency virus-infected woman. 103
Painful neuropathy vasculitis in 2 patients with long-standing human immunodeficiency virus-1 infection. 103
Highly active antiretroviral therapy. 103
M. tuberculosis drug resistance in AIDS 101
Coxsackie B virus-induced autoimmunity to GAD does not lead to type 1 diabetes. 101
Multdrug-resistant tuberculosis 100
Successful treatment of Castleman’s disease with HAART in two HIV-infected patients 100
Diagnosis, management and outcome of clinically-suspected spinal infection 100
mIRTAZAPINE IN AN HIV-INFECTED PATIENT WITH PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 100
Infection with hepatitis G virus in immunoglobulin recipients 97
Initial hospitalization and adherence to highly active antiretroviral therapy. 97
[CD4+ guided interruption HAART in HIV patients] 97
Inflammatory pseudotumor of lymph nodes. 97
Failure of prophylaxis against PCP in patients with HIV infection 96
Response of uncomplicated falciparum malaria to oral chloroquine and quinine in Burundi highlands 96
Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy. 96
Failure of lamivudine therapy for chemotherapy-induced reactivation of hepatitis B. 95
MHC class I molecules and progression to AIDS 93
Syphilis in prostitutes from Eastern Europe. 93
Mediastinal lymphadenitis due to cryptococcal infection in HIV-positive patients on highly active antiretroviral therapy. 92
Effect of pregnancy on chronic hepatitis C 92
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor 92
Human immunodeficiency virus-associated peripheral neuropathies 91
HIV-1 progression in hepatitis-C- infected drug users 90
Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals 90
No influence of nevirapine on vitamin D deficiency in HIV-infected patients 90
Fluconazole penetration into the prostatic fluid of patients with AIDS-associated cryptococcal meningitis. 89
Prevalence and clinical significance of Ureaplasma urealyticum and Mycoplasma hominis in the lower genital tract of HIV-1-infected women. 88
Highly active antiretroviral therapy. 87
Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus 86
Selective drug taking during combination antiretroviral therapy. 86
Efficacy of a reduced dose of darunavir/ritonavir in a cohort of antiretroviral-naive and -experienced HIV-infected patients: a medium-term follow-up 86
Resolution of autoimmune hepatitis after bone-marrow transplantation 85
Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. 84
Isolated Presence of Antibody to Hepatitis B core antigen in injection drug users: do they need to be vaccinated? 81
Esophageal cryptococcosis in a patient with AIDS. 81
No increase in liver decompensation risk with atypical hepatitis C virus antibody pattern. 80
Intracranial mass lesions in HIV/AIDS patients from developing countries endemic for neurocysticercosis. 79
Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital. 75
Long-term efficacy of dual nucleoside reverse transcriptase inhibitor antiretroviral therapy in HIV-1 infection. 69
Short-cycle therapy in {HIV}-infected adults: rilpivirine combination 4 days on/3 days off therapy 68
Prior Mycobacterium avium complex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapy 66
Totale 8.212
Categoria #
all - tutte 30.182
article - articoli 30.182
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.364


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021408 0 0 0 0 90 85 9 74 46 14 79 11
2021/2022640 47 200 7 27 13 20 12 37 29 29 53 166
2022/20231.179 84 113 121 169 139 275 5 76 150 7 25 15
2023/2024406 27 36 44 44 69 51 5 9 2 9 52 58
2024/20251.385 106 83 26 222 60 24 69 37 254 92 93 319
2025/20261.718 293 264 264 760 137 0 0 0 0 0 0 0
Totale 8.212